Introduction Biotechnology has always attracted investors who are looking for innovation-driven growth. Among the many companies making progress, Humacyte Inc. has caught the spotlight. Listed on NASDAQ under the ticker HUMA, the company focuses on creating bioengineered human tissues that can replace or repair damaged blood vessels and organs. This work places Humacyte at the